See more : RE/MAX Holdings, Inc. (RMAX) Income Statement Analysis – Financial Results
Complete financial analysis of Healwell AI Inc. (HWAIF) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Healwell AI Inc., a leading company in the industry within the sector.
You may be interested
- MGC Pharmaceuticals Limited (MGCLF) Income Statement Analysis – Financial Results
- First Capital Real Estate Investment Trust (FCR-UN.TO) Income Statement Analysis – Financial Results
- iFabric Corp. (IFABF) Income Statement Analysis – Financial Results
- EQ Energy Drink, Inc. (EQLB) Income Statement Analysis – Financial Results
- Mount Ridley Mines Limited (MRD.AX) Income Statement Analysis – Financial Results
Healwell AI Inc. (HWAIF)
Website: https://www.healwell.ai
About Healwell AI Inc.
Healwell AI Inc., a healthcare technology company, focuses on AI and data science for preventative care. It offers AI-enabled decision support platform for healthcare providers. Healwell AI Inc. has a strategic alliance agreement with WELL Health Technologies Corp to enhance the growth and development of AI-enabled healthcare technologies. The company was formerly known as MCI Onehealth Technologies Inc. and changed its name to Healwell AI Inc. in October 2023. Healwell AI Inc. was incorporated in 2012 and is headquartered in Toronto, Canada.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | 7.32M | 10.42M | 47.82M | 38.57M | 46.29M |
| Cost of Revenue | 6.06M | 6.71M | 32.81M | -25.65M | 31.03M |
| Gross Profit | 1.26M | 3.71M | 15.01M | 64.22M | 15.26M |
| Gross Profit Ratio | 17.18% | 35.59% | 31.39% | 166.49% | 32.97% |
| Research & Development | 4.81M | 8.14M | 155.00K | 0.00 | 0.00 |
| General & Administrative | 9.06M | 11.36M | 30.18M | 13.61M | 13.53M |
| Selling & Marketing | 1.28M | 1.52M | 1.12M | 125.00K | 0.00 |
| SG&A | 14.04M | 12.88M | 31.30M | 13.74M | 13.53M |
| Other Expenses | 0.00 | 194.00K | 28.00K | 19.00K | 1.87M |
| Operating Expenses | 18.85M | 21.03M | 31.45M | 13.74M | 16.55M |
| Cost & Expenses | 24.91M | 27.74M | 64.26M | -11.91M | 47.58M |
| Interest Income | 0.00 | 20.00K | 109.00K | 64.00K | 76.00K |
| Interest Expense | 0.00 | 618.00K | 462.00K | 497.00K | 536.00K |
| Depreciation & Amortization | 1.48M | 2.54M | 4.31M | 2.96M | 3.12M |
| EBITDA | -16.11M | -15.01M | -11.52M | 2.11M | 3.63M |
| EBITDA Ratio | -220.21% | -143.98% | -25.36% | 5.48% | 7.87% |
| Operating Income | -17.59M | -17.55M | -16.43M | -842.00K | 523.00K |
| Operating Income Ratio | -240.43% | -168.34% | -34.37% | -2.18% | 1.13% |
| Total Other Income/Expenses | -15.09M | 1.13M | 1.85M | 19.00K | -1.45M |
| Income Before Tax | -32.68M | -17.08M | -16.29M | -1.34M | -30.00K |
| Income Before Tax Ratio | -446.67% | -163.81% | -34.06% | -3.47% | -0.06% |
| Income Tax Expense | 542.00K | 1.12M | -747.00K | -312.00K | 91.00K |
| Net Income | -31.60M | -21.09M | -15.67M | -1.03M | -122.00K |
| Net Income Ratio | -431.83% | -202.27% | -32.77% | -2.67% | -0.26% |
| EPS | -0.56 | -0.42 | -0.33 | -0.03 | 0.00 |
| EPS Diluted | -0.56 | -0.42 | -0.33 | -0.03 | 0.00 |
| Weighted Avg Shares Out | 57.03M | 50.08M | 48.00M | 38.33M | 38.01M |
| Weighted Avg Shares Out (Dil) | 57.03M | 50.08M | 48.00M | 38.33M | 38.00M |
HEALWELL Acquires Control of Mutuo Health Solutions to Build Next Generation of AI-Powered Physician Co-Pilots
HEALWELL has acquired a majority controlling interest in Mutuo Health Solutions, a Toronto-based medical artificial intelligence company focused on developing predictive clinical AI technology. Mutuo Health's AutoScribe platform is an advanced AI-powered ambient scribe solution that transcribes clinician-patient interactions into...
HEALWELL's VeroSource Solutions Provides Corporate Update Demonstrating Rapid Growth and Expansion Across Canadian Public Sector Clients
More than 600,000 New Brunswick residents are now eligible to generate a Patient Summary on the VeroSource-built MyHealthNB digital front door. This year, MyHealthNB averaged over 35,000 unique monthly users in New Brunswick, reflecting 100% growth compared to 2023.
HEALWELL AI Appoints Beatrice York, Dr. Marcel Reichart, and Reeva Misra to Strategic Advisory Board
HEALWELL AI announces the formation of a Strategic Advisory Board, designed to empower the Company's global growth initiatives and offer expert guidance on product development, ethical considerations related to use of AI, regulatory compliance, and market positioning. Beatrice York, Dr....
HEALWELL Reports Record Revenue and Increased Customer Activity from Pharmaceutical Partners in Q3-2024
HEALWELL achieved record quarterly revenue from continuing operations of $13.7 million in Q3-2024, 738% higher than the $1.6 million generated in Q3-2023 and 153% higher than the $5.4 million generated in Q2-2024. Quarterly revenues were driven by HEALWELL completing the...
HEALWELL's Pentavere Receives Prestigious Prix Galien USA 2024 Award for Best Digital Health Startup for Its Contributions in AI for Life Sciences Industry
The Prix Galien Award is among the global health innovation industry's most renowned honors, recognizing outstanding biomedical, medical, and technology achievements that improve the human condition and is considered the industry's equivalent of the Nobel Prize. Pentavere's DARWEN™ AI platform...
HEALWELL Provides Corporate Update on Accelerating Commercialization and Expansion of Pharmaceutical Partnerships by Leveraging Its Best-in-Class Patient Identification Capabilities
HEALWELL's AI and data science subsidiaries have executed 5 new Master Services Agreements ("MSA") with new pharmaceutical partners in Q3-2024; bringing the total number of MSAs with life sciences partners to 27, which includes 6 of the top 10 pharmaceutical...
HEALWELL AI to Announce Third Quarter 2024 Financial Results on November 12, 2024
HEALWELL AI to hold a conference call and simultaneous webcast on Tuesday, November 12, 2024, at 1:00 pm EST (10:00 am PST). Toronto, Ontario--(Newsfile Corp. - November 4, 2024) - HEALWELL AI Inc. (TSX: AIDX) (OTCQX: HWAIF) ("HEALWELL" or the...
WELL Health and HEALWELL AI Expand Strategic Alliance Agreement to Develop an AI-Enhanced Clinical Trials Program to Accelerate Innovation and Improve Patient Outcomes
WELL Health and HEALWELL AI announce the expansion of their multi-year agreement that allows WELL and HEALWELL to launch and manage clinical trial sites at WELL Health clinic locations across Canada. Leveraging HEALWELL's Contract Research Organization (CRO) capabilities alongside WELL Health's...
WELL Health and HEALWELL AI Expand Strategic Alliance Agreement to Develop an AI-Enhanced Clinical Trials Program to Accelerate Innovation and Improve Patient Outcomes
WELL Health and HEALWELL AI announce the expansion of their multi-year agreement that allows WELL and HEALWELL to launch and manage clinical trial sites at WELL Health clinic locations across Canada. Leveraging HEALWELL's Contract Research Organization (CRO) capabilities alongside WELL...
HEALWELL AI Announces Strategic Investment and Commercialization Agreement with Abstractive Health to Advance Generative AI-Powered Clinical Documentation Solutions
HEALWELL AI completes a strategic investment in NY-based Abstractive Health, alongside lead investor Rho Capital Partners, to support the development of AI-driven clinical documentation technology. Concurrent with the investment, HEALWELL also entered into a commercial agreement with Abstractive Health that...
Source: https://incomestatements.info
Category: Stock Reports